Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate vs Triamcinolone Acetonide With Microneedling in Recalcitrant Alopecia Areata
NCT06088147Unknown
- Sponsor
- Al-Azhar University
- Start
- Dec 2023
- Primary completion
- Mar 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Trial of methotrexate in alopecia areata (2 arms), sponsored by Al-Azhar University. Primary endpoint: Efficacy of Methotrexate vs Triamcinolone at 6 months. Status: unknown.
02
Drugs
methotrexate
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT06088147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06088147.